申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2020231766A1
公开(公告)日:2020-11-19
The present invention is directed to compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
本发明涉及以下化合物的公式,其中所有取代基在此定义,以及包括该发明化合物的药学上可接受的组合物,以及使用这些组合物治疗各种疾病的方法。